AQUIS STOCK EXCHANGE
Pharma C Investments (PCIL) has received a general meeting requisition from one of its shareholders. The directors are reviewing the request.
Technology marketing start-up Inteliqo (IQO) generated income of more than $400,000 and pre-tax profit of $250,000 from the distribution rights of the Langaroo app, which has still to be launched on Google Play and the Apple app store.
Macaulay Capital (MCAP) has realised one of the five investments it took on from Chelverton Asset Management. Qualification Check B shares were bought by a trade buyer, and this will generate fees that will be shared by Macaulay Capital and Chelverton Asset Management. The net amount receivable by Macaulay Capital is £212,000.
Guanajuato Silver Company (GSVR) generated record production of 941,338 silver equivalent ounces in the second quarter and all-in sustaining cost was $22.47/ounce. Realised prices improved on the previous quarter. There was a small dip in net loss of $8.5m. Drill results from the Topia mine in Durango, Mexico have been promising.
Capital for Colleagues (LON: CFCP) investee company Bright Ascension provides software for the space sector, and it has been selected to lead onboard and ground software development for the three-year OS2-VOLT mission. This OS2-VOLT mission is being led by another investee company, Craft Prospect.
Marula Mining (MARU) has moved to the Apex section of the market. The construction of the initial modular processing plant for the Kinusi copper mine has been completed and is ready for transportation and commissioning.
Rogue Baron (SHNJ) raised £50,000 at 0.75p/share.
Coinsilium Group Ltd (COIN) chief executive Eddy Travia bought 1.5 million shares at 1.25p each.
Andrew Offit has taken a 4.77% stake in AQRU (AQRU).
AIM
Education software and services provider Tribal (TRB) reported a 2% increase in interim revenues even though the NTU project has been cancelled. Annualised recurring revenues are 3% ahead at £51.9m. The NTU project is still the subject of dispute, but there will be no more non-legal costs. The second half is expected to be better and pre-tax profit is forecast to recover from £3.7m to £9.1m.
Loyalty technology provider Eagle Eye (EYE) has revealed that a previously announced three-year contract is with department stores operator Hudson Bay Company, which was formed in the seventeenth century and who’s backers included Prince Rupert. Hudson Bay Company will relaunch its digital loyalty programme using Eagle Eye technology.
Fulcrum Utility Services (FCRM) intends to seek shareholder approval to leave AIM. This announcement followed the release of full year figures showing an increased loss. The utility infrastructure business reported a £25.7m loss on a 18% decrease in revenues to £50.6m. Even excluding write-downs and restructuring charges there was a loss.
Compliance and maintenance services provider Kinovo (KINO) revealed a non-binding bid approach from Rx3 Holdings, which the bid target said was at 56p/share. Management says that the offer is at the lower end of board expectations. Rx3 has confirmed that the offer price will be at least 40p/share, because 29.9% shareholder Tipacs2 Ltd recently bought shares at that price from Western Selection (WESP).
Wellhead equipment supplier Plexus Holdings (POS) says a £5m rental contract for POS-GROP HG wellhead equipment and sealing technology announced in March has been increased in value to £8m. These revenues will be recognised in the year to June 2024, which should enable Plexus to move into profit. The 2021-22 revenues were £2.31m and they are expected to decline in 2022-23.
Bivictrix Therapeutics (BVX) has been granted a US patent for lead asset BVX001 and it expects to gain a Japanese patent in a few weeks. BVX001 is an antibody drug conjugate than targets leukaemia.
Cake Box (CBOX) reported like-for-like sales growth of 6.8% in the first 17 weeks of the financial year. That represents an acceleration of growth in recent weeks as marketing is stepped up. There are 212 outlets with scope for more. After paying the final dividend there is £6m in the bank.
Redx Pharma (REDX) says zelasudil (RXC007), an oral, selective Rho Associated Coiled-Coil Containing Protein Kinase 2 (ROCK2) inhibitor, has received Orphan Drug Designation from the FDA for the potential treatment of Idiopathic Pulmonary Fibrosis (IPF). The treatment is being used in a phase 2a clinical study for IPF and data is expected in the first quarter of next year. IPF is a disease of the lungs which progressively causes scarring and a reduction in lung function.
Neometals (NMT) says battery recycling joint venture Primobius has received an order for 10 tonne/day of lithium-ion battery recycling spoke with Mercedes. The facility will recover lithium, cobalt, nickel, manganese and other materials and feed them back into production of 50,000 batteries for new Mercedes vehicles. This is important because it will help the joint venture to gain credibility and win more business.
Cybersecurity firm Shearwater Group (SWG) has delayed publication of its full year results due to audit delays. They are set to be published on 5 September. On a brighter note, delayed contracts have been received in the first quarter of the new financial year. Market conditions are becoming more favourable.
Coro Energy (CORO) has sold its 18.76% stake in ion Ventures for £1.25m in cash, of which £250,000 is deferred until March 2024. The book value was $259,000.
MAIN MARKET
Graft Polymer (UK) (GPL) signed a manufacturing services agreement for production of haemostatic wound care products. The partner is in the Israel pharma market and the Graft Bio facility will provide manufacturing services for the partner’s patented haemostatic powder. This changes from a self-emulsifying powder to a gel when coming into contact with blood, thereby helping to clot the blood effectively.
Ferro-Alloy Resources (FAR) warns that problems with the delivery of concentrate material to its secondary processing facility will hit third quarter results. This follows record second quarter vanadium, molybdenum and nickel production.
Zamaz (ZAMZ) is changing its name to Dispensa, although the strategy remains the same. It will acquire growing, speciality food brands.
Ashington Innovation (ASHI) has signed heads of terms for the acquisition of Calon Cardio-Technology. Calon is developing a left ventricular asset device, an implantable heart pump for patients with severe heart failure.
Mode Group Holdings (MODE) is changing its name to R8 Capital.
Andrew Hore
